Digital Landscape-HIV: Lack of Pharma-Sponsored Social Medial Activities to Limit Growth
Under the term, digital landscape: HIV, various digital activities undertaken by pharma in support of therapies for the treatment of HIV have been considered. US patient landscape is dominated by Gilead, ViiV and Janssen, with Gilead providing the most complete HIV digital offering. Gilead and ViiV provide the best unbranded support. Lack of pharma-sponsored social media initiatives that provide patients with a sense of community. Limited HIV mobile app support in the US from pharma, with Gilead providing the only...
View full press release